Pharming Group N.V. (LON:0QCO)
London flag London · Delayed Price · Currency is GBP · Price in EUR
1.355
-0.023 (-1.64%)
At close: Feb 11, 2026

Pharming Group Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
776519599627422727
Market Cap Growth
65.93%-13.36%-4.52%48.55%-41.93%-12.75%
Enterprise Value
750486571582409705
Last Close Price
1.170.760.900.970.651.14
PE Ratio
2730.29--55.2735.7526.30
PS Ratio
2.882.193.113.682.884.68
PB Ratio
3.942.943.493.692.965.41
P/TBV Ratio
8.044.065.175.825.2310.47
P/FCF Ratio
19.78--35.8521.1012.57
P/OCF Ratio
19.56--33.6615.1111.87
EV/Sales Ratio
2.792.052.973.412.784.54
EV/EBITDA Ratio
19.99188.69-40.9718.2211.66
EV/EBIT Ratio
24.81--67.7023.0712.62
EV/FCF Ratio
19.12--33.2920.4312.19
Debt / Equity Ratio
0.500.510.780.820.840.88
Debt / EBITDA Ratio
2.5517.02-8.464.881.92
Debt / FCF Ratio
2.48--7.915.972.05
Asset Turnover
0.810.690.550.500.490.63
Inventory Turnover
0.570.630.510.500.871.26
Quick Ratio
2.392.963.283.904.693.09
Current Ratio
3.163.774.064.655.333.43
Return on Equity (ROE)
0.03%-5.38%-4.98%6.88%8.50%25.09%
Return on Assets (ROA)
5.76%-0.52%-3.06%1.57%3.68%14.13%
Return on Invested Capital (ROIC)
0.08%-2.10%-12.76%5.79%10.98%54.07%
Return on Capital Employed (ROCE)
10.70%-1.10%-5.70%2.80%6.80%22.30%
Earnings Yield
0.04%-1.82%-1.38%1.81%2.80%3.80%
FCF Yield
5.05%-0.40%-2.46%2.79%4.74%7.95%
Buyback Yield / Dilution
2.65%-2.18%7.09%-0.85%-2.70%-1.37%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.